WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity,foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.
更新时间:2025-07-11 直链:westvacpharma.com
Withmorethan200professionalexpertsinvitrodiagnosticR&Dteam,wehaveestablished6IVDtechnologyplatforms,includingimmunofluorescence,colloidalgold,urinalysis,bloodcellanalysis,biochemicalanalysis,andmoleculardiagnosis.
更新时间:2025-07-06 直链:dialovet.com
Nationalhigh-techbiotechnologyenterpriseintegratingR&D,production,thefounderteamofthecompanycomesfromfamousuniversitiesathomeandabroad.
更新时间:2025-07-03 直链:en.genfine.com
Zeta-Life,Isaprofessionalengagedinlifescienceinstrumentsandreagentsagentsalesandservices,oneofthewell-knownenterprises.Ouragentathomeandabroadwell-knownbiotechnologyproducts,salesoftheinstruments,consumables,molecularandbiochemicalreagent,immunologicalreagentsandcellculturereagents,hasbeenwidelyusedinlifescienceresearch,developmentandapplication,pharmacy,diseasediagnosisandcontrol,populationandhealth,biologytechnologyfields.CustomersthroughouttheUniversity,ResearchInstitute,hospitals,healthandepidemicprevention,commodityinspectionandquarantine,pharmaceuticalcompanies,BiotechCorpandfoodindustryandotherunits.
更新时间:2025-06-29 直链:zeta-life.com
LeicaBiosystemsisagloballeaderinworkflowsolutionsandautomation,integratingeachstepintheworkflowfrombiopsytodiagnosis.
更新时间:2025-06-25 直链:www.leicabiosystems.com
武汉明德生物科技股份有限公司,股票代码002932,是一家专业提供体外诊断设备和试剂(POCT化学发光分子诊断血气分析干式生化)及临床医疗服务(胸痛中心卒中中心心电网络)的国家高新技术企业。国内高通量POCT领导者,胸痛中心、卒中中心及心电网络建设领先者。
更新时间:2025-06-24 直链:mdeasydiagnosis.com